Citations

Mayo Clinic

Showing 10 of 108551 citations.

Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain
He, Shuning , Mansour, Marc R. , Ki, Dong Hyuk , Layden, Hillary M. , Gjini, Evisa , Groh, Eric D. de, Zhu, Shizhen , Epstein, Jonathan A. , Look, A. Thomas , Look, A Thomas , Zimmerman, Mark W. , Akahane, Koshi , Pérez‐Atayde, Antonio R.

eLife | April 27, 2016 | Volume: 5 | Issue: No issue available | Pages: No page available

10.7554/elife.14713 | PMID 27130733 Get It

Earlier reports showed that hyperplasia of sympathoadrenal cell precursors during embryogenesis in Nf1-deficient mice is independent of Nf1’s role in down-modulating RAS-MAPK signaling. We demonstrate in zebrafish that nf1 loss leads to aberrant activation of RAS signaling in MYCN-induced neuroblastomas that arise in these precursors, and that the GTPase-activating protein (GAP)-related domain (GRD) is sufficient to suppress the acceleration of neuroblastoma in nf1-deficient fish, but not the hypertrophy of sympathoadrenal cells in nf1 mutant embryos. Thus, even though neuroblastoma is a classical “developmental tumor”, NF1 relies on a very different mechanism to suppress malignant transformation than it does to modulate normal neural crest cell growth. We also show marked synergy in tumor cell killing between MEK inhibitors (trametinib) and retinoids (isotretinoin) in primary nf1a-/- zebrafish neuroblastomas. Thus, our model system has considerable translational potential for investigating new strategies to improve the treatment of very high-risk neuroblastomas with aberrant RAS-MAPK activation.
The Human Person at the Heart of Medicine: Reflections of a Physician with Lymphoma
Manning, Dennis M., Manning, Dennis Michael

The Linacre Quarterly | April 27, 2016 | Volume: 83 | Issue: 1 | Pages: 15-19

10.1080/00243639.2016.1143169 | PMID 27833178 Get It

The author, a physician living with lymphoma for five years, relates the details of the lived experience. He reflects on the impact of his illness on aspects of his life: personal health, professional work as a physician, and his journey in faith.
Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer
Xia, Yun , Huang, Chiang‐Ching , Dittmar, Rachel L. , Du, Meijun , Liu, Hongyan , Shenoy, Niraj , Kohli, Manish , Wang, Yuan , Wang, Liang , Kohli, Manish , Shenoy, Niraj

Oncotarget | April 27, 2016 | Volume: 7 | Issue: 24 | Pages: 35818-35831

10.18632/oncotarget.9027 | PMID 27127882 Get It

Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics
Shivkumar, Kalyanam , Ajijola, Olujimi A. , Anand, Inder S. , Armour, J. Andrew, Chen, Peng‐Sheng , Esler, Murray , Ferrari, Gaetano Maria De , Fishbein, Michael C. , Harper, Ronald M. , Joyner, Michael J. , Khalsa, Sahib S. , Lane, Richard D. , Mahajan, Aman , Po, Sunny S. , Valderrábano, Miguel , Vaseghi, Marmar , Goldberger, Jeffrey J , Kumar, Rajesh , Schwartz, Peter J. , Somers, Virend K. , Zipes, Douglas P. , Shivkumar, Kalyanam , Anand, Inder S , Joyner, Michael J , Khalsa, Sahib S

The Journal of Physiology | April 27, 2016 | Volume: 594 | Issue: 14 | Pages: 3911-3954

10.1113/jp271870 | PMID 27114333 Get It

AbstractThe autonomic nervous system regulates all aspects of normal cardiac function, and is recognized to play a critical role in the pathophysiology of many cardiovascular diseases. As such, the value of neuroscience‐based cardiovascular therapeutics is increasingly evident. This White Paper reviews the current state of understanding of human cardiac neuroanatomy, neurophysiology, pathophysiology in specific disease conditions, autonomic testing, risk stratification, and neuromodulatory strategies to mitigate the progression of cardiovascular diseases.
PPP6R3‐USP6 amplification: Novel oncogenic mechanism in malignant nodular fasciitis
Guo, Ruifeng, Chou, Margaret M. , Asmann, Yan W. , Wenger, Doris E. , Al‐Ibraheemi, Alyaa , Molavi, Diana Weedman, Aboulafia, Albert J. , Jin, Long , Fritchie, Karen , Oliveira, Jennifer L. , Jenkins, Robert B. , Dong, Jie , Oliveira, André M. , Guo, Ruifeng , Herrick, Jennifer L. , Wang, Xiaoke, Asmann, Yan, Al-Ibraheemi, Alyaa, Guo, Ruifeng, Wang, Xiaoke, Westendorf, Jennifer J. , Guo, Ruifeng

Genes, Chromosomes and Cancer | April 27, 2016 | Volume: 55 | Issue: 8 | Pages: 640-649

10.1002/gcc.22366 | PMID 27113271 Get It

Nodular fasciitis (NF) is a clonal self‐limited neoplastic proliferation characterized by rearrangements of the USP6 locus in most examples. To our knowledge well‐documented malignant behavior has never been previously observed in NF. In this report we present an unusual case of NF with classical histologic features that showed a protracted clinical course characterized by multiple recurrences and eventual metastatic behavior over a period of 10 years. Molecular analyses revealed the presence and amplification of the novel PPPR6‐USP6 gene fusion, which resulted in USP6 mRNA transcriptional upregulation. These findings further support the oncogenic role of the USP6 protease in mesenchymal neoplasia and expand the biologic potential of NF. © 2016 Wiley Periodicals, Inc.
Effect of NBCe1 deletion on renal citrate and 2-oxoglutarate handling
Osis, Gunars , Handlogten, Mary E., Lee, Hyun‐Wook , Hering-Smith, Kathleen S. , Romero, Michael F. , Verlander, Jill W. , Weiner, I. David , Huang, Weitao, Weiner, I David , Romero, Michael F

Physiological Reports | April 27, 2016 | Volume: 4 | Issue: 8 | Pages: e12778

10.14814/phy2.12778 | PMID 27117802 Get It

Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients
Tang, Xiaojing , Brown, Matthew , Cogal, Andrea G. , Gauvin, Daniel, Harris, Peter C. , Romero, Michael F. , Chang, Min‐Hwang , Lieske, John C. , Harris, Peter C , Brown, Matthew R , Romero, Michael F

Physiological Reports | April 26, 2016 | Volume: 4 | Issue: 8 | Pages: e12776

10.14814/phy2.12776 | PMID 27117801 Get It

Faculty Opinions recommendation of Patients with Complicated Intra-Abdominal Infection Presenting with Sepsis Do Not Require Longer Duration of Antimicrobial Therapy.
Chua, Heidi K

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 26, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726257082.793517181 Get It

Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration
Monette, Jeffrey S., Hutchins, Patrick M., Ronsein, Graziella E. , Wimberger, Jake , Irwin, Angela D. , Tang, Chongren, Sara, Jaskanwal Deep Singh , Vaisar, Tomáš , Heinecke, Jay W. , Sara, Jaskanwal D, Shao, Baohai, Shao, Baohai , Lerman, Amir

Circulation Research | April 26, 2016 | Volume: 119 | Issue: 1 | Pages: 83-90

10.1161/circresaha.116.308357 | PMID 27114438 Get It

Rationale: Coronary endothelial dysfunction (ED)—an early marker of atherosclerosis—increases the risk of cardiovascular events. Objective: We tested the hypothesis that cholesterol efflux capacity and high-density lipoprotein (HDL) particle concentration predict coronary ED better than HDL-cholesterol (HDL-C). Methods and Results: We studied 80 subjects with nonobstructive (<30% stenosis) coronary artery disease. ED was defined as <50% change in coronary blood flow in response to intracoronary infusions of acetylcholine during diagnostic coronary angiography. Cholesterol efflux capacity and HDL particle concentration (HDL-P IMA ) were assessed with validated assays. Cholesterol efflux capacity and HDL-P IMA were both strong, inverse predictors of ED ( P <0.001 and 0.005, respectively). In contrast, HDL-C and other traditional lipid risk factors did not differ significantly between control and ED subjects. Large HDL particles were markedly decreased in ED subjects (33%; P =0.005). After correction for HDL-C, both efflux capacity and HDL-P IMA remained significant predictors of ED status. HDL-P IMA explained cholesterol efflux capacity more effectively than HDL-C ( r =0.54 and 0.36, respectively). The efflux capacities of isolated HDL and serum HDL correlated strongly ( r =0.49). Conclusions: Cholesterol efflux capacity and HDL-P IMA are reduced in subjects with coronary ED, independently of HDL-C. Alterations in HDL-P IMA and HDL itself account for a much larger fraction of the variation in cholesterol efflux capacity than does HDL-C. A selective decrease in large HDL particles may contribute to impaired cholesterol efflux capacity in ED subjects. These observations support a role for HDL size, concentration, and function as markers—and perhaps mediators—of coronary atherosclerosis in humans.